Indivior Pharmaceuticals (INDV) Receivables - Net (2021 - 2025)
Historic Receivables - Net for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $259.0 million.
- Indivior Pharmaceuticals' Receivables - Net rose 318.73% to $259.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $259.0 million, marking a year-over-year increase of 318.73%. This contributed to the annual value of $254.0 million for FY2024, which is 0.0% changed from last year.
- Per Indivior Pharmaceuticals' latest filing, its Receivables - Net stood at $259.0 million for Q3 2025, which was up 318.73% from $240.0 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Receivables - Net ranged from a high of $259.0 million in Q2 2024 and a low of $202.0 million during Q4 2021
- Over the past 5 years, Indivior Pharmaceuticals' median Receivables - Net value was $247.0 million (recorded in 2023), while the average stood at $242.1 million.
- Per our database at Business Quant, Indivior Pharmaceuticals' Receivables - Net skyrocketed by 1545.45% in 2023 and then tumbled by 733.59% in 2025.
- Quarter analysis of 5 years shows Indivior Pharmaceuticals' Receivables - Net stood at $202.0 million in 2021, then grew by 8.91% to $220.0 million in 2022, then grew by 15.45% to $254.0 million in 2023, then changed by 0.0% to $254.0 million in 2024, then grew by 1.97% to $259.0 million in 2025.
- Its Receivables - Net stands at $259.0 million for Q3 2025, versus $240.0 million for Q2 2025 and $243.0 million for Q1 2025.